abstract |
The invention relates to fully human antibodies, and fragments thereof, that bind to human interferon gamma (hlFNϜ), thereby modulating the interaction between IFNϜ and its receptor, IFNϜ-R, and/or modulating the biological activities of IFNϜ. The invention also relates to the use of such anti-IFNϜ antibodies in the prevention or treatment of immune- related disorders and in the amelioration of a symptom associated with an immune-related disorder. |